Suppr超能文献

含泡腾混合物的新型“胶囊中片剂系统”中活性药物成分释放的调控

Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.

作者信息

Gohel Mukesh C, Sumitra G Manhapra

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad 380 009, Gujarat, India.

出版信息

J Control Release. 2002 Feb 19;79(1-3):157-64. doi: 10.1016/s0168-3659(01)00541-7.

Abstract

The objective of the present study was to obtain programmed drug delivery from hard gelatin capsules containing a hydrophilic plug (HPMC or guar gum). The significance of factors such as type of plug (powder or tablet), plug thickness and the formulation of fill material on the release pattern of diltiazem HCl, a model drug, was investigated. The body portion of the hard gelatin capsules was cross-linked by the combined effect of formaldehyde and heat treatment. A linear relationship was observed between weight of HPMC K15M and log % drug released at 4 h from the capsules containing the plug in powder form. In order to accelerate the drug release after a lag time of 4 h, addition of an effervescent blend, NaHCO(3) and citric acid, in the capsules was found to be essential. The plugs of HPMC in tablet form, with or without a water soluble adjuvant (NaCl or lactose) were used for obtaining immediate drug release after the lag time. Sodium chloride did not cause significant influence on drug release whereas lactose favourably affected the drug release. The capsules containing HPMC K15M tablet plug (200 mg) and 35 mg effervescent blend in body portion of the capsule met the selection criteria of less than 10% drug release in 4 h and immediate drug release thereafter. It is further shown that the drug release was also dependant on the type of swellable hydrophilic agent (HPMC or guar gum) and molecular weight of HPMC (K15M or 20 cPs). The results reveal that programmed drug delivery can be obtained from hard gelatin capsules by systemic formulation approach.

摘要

本研究的目的是从含有亲水性栓塞(羟丙基甲基纤维素或瓜尔胶)的硬明胶胶囊中实现程序性药物递送。研究了诸如栓塞类型(粉末或片剂)、栓塞厚度以及填充材料配方等因素对模型药物盐酸地尔硫䓬释放模式的影响。硬明胶胶囊的主体部分通过甲醛和热处理的联合作用进行交联。观察到在含有粉末形式栓塞的胶囊中,羟丙基甲基纤维素K15M的重量与4小时时药物释放的对数百分比之间存在线性关系。为了在4小时的滞后时间后加速药物释放,发现向胶囊中添加泡腾混合物(碳酸氢钠和柠檬酸)至关重要。使用含有或不含有水溶性辅料(氯化钠或乳糖)的片剂形式的羟丙基甲基纤维素栓塞,以在滞后时间后实现即时药物释放。氯化钠对药物释放没有显著影响,而乳糖对药物释放有有利影响。在胶囊主体部分含有羟丙基甲基纤维素K15M片剂栓塞(200毫克)和35毫克泡腾混合物的胶囊符合4小时内药物释放小于10%且此后即时药物释放的选择标准。进一步表明,药物释放还取决于可溶胀亲水性剂的类型(羟丙基甲基纤维素或瓜尔胶)以及羟丙基甲基纤维素的分子量(K15M或20厘泊)。结果表明,通过系统的配方方法可以从硬明胶胶囊中获得程序性药物递送。

相似文献

3
Highly specific colon-targeted transformable capsules containing indomethacin immediate-release pellets for colon cancers therapy.
J Drug Target. 2020 Jan;28(1):102-110. doi: 10.1080/1061186X.2019.1620751. Epub 2019 Jul 22.
4
A novel system for three-pulse drug release based on "tablets in capsule" device.
Int J Pharm. 2008 Mar 20;352(1-2):159-64. doi: 10.1016/j.ijpharm.2007.10.043. Epub 2007 Nov 4.
5
Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
Drug Deliv. 2011 Nov;18(8):620-30. doi: 10.3109/10717544.2011.621987.
6
Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
Drug Dev Ind Pharm. 2005 Jan;31(1):79-89. doi: 10.1081/ddc-44010.
10
Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.
AAPS PharmSciTech. 2011 Mar;12(1):77-87. doi: 10.1208/s12249-010-9570-1. Epub 2010 Dec 21.

引用本文的文献

1
Drug release behavior of polymeric matrix filled in capsule.
Saudi Pharm J. 2016 Nov;24(6):627-634. doi: 10.1016/j.jsps.2015.04.003. Epub 2015 May 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验